Ocular Therapeutix Inc
OCUL
Market Cap$1.44B
Close$
$10.44
15.7% upside
Current Fair Value
15.7% upsideUndervalued by 15.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.44 Billion |
|---|---|
| Enterprise Value | $1.16 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.22 |
| Beta | 1.41 |
| Outstanding Shares | 169,396,989 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.93 |
|---|---|
| PEG | 646.75 |
| Price to Sales | - |
| Price to Book Ratio | 9.02 |
| Enterprise Value to Revenue | 19.55 |
| Enterprise Value to EBIT | -5.76 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ocular Therapeutix Inc
CEO: Antony Mattessich